Your browser doesn't support javascript.
loading
Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2.
Tenbusch, Matthias; Schumacher, Sofie; Vogel, Emanuel; Priller, Alina; Held, Jürgen; Steininger, Philipp; Beileke, Stephanie; Irrgang, Pascal; Brockhoff, Ronja; Salmanton-García, Jon; Tinnefeld, Kathrin; Mijocevic, Hrvoje; Schober, Kilian; Bogdan, Christian; Yazici, Sarah; Knolle, Percy; Cornely, Oliver A; Überla, Klaus; Protzer, Ulrike.
Afiliação
  • Tenbusch M; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Schumacher S; University Hospital of Cologne, Faculty of Medicine, Department I of Internal Medicine, Cologne, Germany; University of Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, Cologne, Germany.
  • Vogel E; Institute of Virology, School of Medicine, Technical University of Munich/Helmholtz Zentrum München, 81675 Munich, Germany.
  • Priller A; Institute of Molecular Immunology and Experimental Oncology, School of Medicine, University Hospital rechts der Isar, Technical University of Munich, Munich, Germany.
  • Held J; Mikrobiologisches Institut-Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Steininger P; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Beileke S; Mikrobiologisches Institut-Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Irrgang P; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Brockhoff R; University Hospital of Cologne, Faculty of Medicine, Department I of Internal Medicine, Cologne, Germany; University of Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, Cologne, Germany.
  • Salmanton-García J; University Hospital of Cologne, Faculty of Medicine, Department I of Internal Medicine, Cologne, Germany; University of Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, Cologne, Germany.
  • Tinnefeld K; Institute of Virology, School of Medicine, Technical University of Munich/Helmholtz Zentrum München, 81675 Munich, Germany.
  • Mijocevic H; Institute of Virology, School of Medicine, Technical University of Munich/Helmholtz Zentrum München, 81675 Munich, Germany.
  • Schober K; Mikrobiologisches Institut-Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Bogdan C; Mikrobiologisches Institut-Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Yazici S; Institute of Molecular Immunology and Experimental Oncology, School of Medicine, University Hospital rechts der Isar, Technical University of Munich, Munich, Germany.
  • Knolle P; Institute of Molecular Immunology and Experimental Oncology, School of Medicine, University Hospital rechts der Isar, Technical University of Munich, Munich, Germany; DZIF, partner sites Munich and Cologne/Bonn, Germany.
  • Cornely OA; University Hospital of Cologne, Faculty of Medicine, Department I of Internal Medicine, Cologne, Germany; University of Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, Cologne, Germany.
  • Überla K; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Protzer U; Institute of Virology, School of Medicine, Technical University of Munich/Helmholtz Zentrum München, 81675 Munich, Germany; DZIF, partner sites Munich and Cologne/Bonn, Germany. Electronic address: protzer@tum.de.
Lancet Infect Dis ; 21(9): 1212-1213, 2021 09.
Article em En | MEDLINE | ID: mdl-34332707
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunização Secundária / Anticorpos Neutralizantes / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Lancet Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunização Secundária / Anticorpos Neutralizantes / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Lancet Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha